01—Abstract
Summary
Summary of the 8-K filed January 14, 2025. Cited figures are marked; the original filing is the authoritative source.
Cardinal Health Inc. (CAH) has announced an upward revision to its fiscal year 2025 non-GAAP diluted earnings per share (EPS) guidance.
The company now expects its non-GAAP EPS to be toward the high end of its previously stated range of $7.75 to $7.90a. This positive adjustment is primarily attributed to the sustained strong performance within its Pharmaceutical and Specialty Solutions segment. Investors should note that the company will be presenting at the JP Morgan 43rd Annual Healthcare Conference on January 14, 2025, where further commentary on this update is expected.
Additionally, more comprehensive details regarding fiscal year 2025 expectations will be provided during the second quarter earnings call scheduled for January 30, 2025. The company emphasizes that it does not provide forward-looking guidance on a GAAP basis due to the unavailability of certain significant financial information.
02—Key points
Key Highlights
- Cardinal Health raises FY2025 non-GAAP EPS outlook to the high end of the $7.75-$7.90 range.
- The positive revision is driven by strong performance in the Pharmaceutical and Specialty Solutions segment.
- The company will provide further commentary on this update at the JP Morgan Healthcare Conference on January 14, 2025.
- Additional details on FY2025 expectations will be shared during the Q2 earnings call on January 30, 2025.
- Cardinal Health does not provide forward-looking guidance on a GAAP basis.
- The filing includes standard cautionary statements regarding forward-looking statements and associated risks.
03—Questions
Frequently Asked Questions
What is the main reason for the updated earnings guidance?
The primary driver for the updated guidance is the continued strong performance observed within Cardinal Health's Pharmaceutical and Specialty Solutions segment.
When can investors expect more details on the company's financial outlook?
Investors can expect further commentary on this update during the JP Morgan Healthcare Conference presentation on January 14, 2025, and more comprehensive details will be provided on the second quarter earnings call on January 30, 2025.
Why does Cardinal Health not provide GAAP forward-looking guidance?
Cardinal Health does not provide forward-looking guidance on a GAAP basis because certain financial information, whose probable significance cannot be determined, is not yet available and cannot be reasonably estimated.
What are some of the key risks mentioned in the filing that could impact future performance?
Key risks include challenges in executing strategic objectives like the GMPD Improvement Plan, inflationary pressures, potential tariffs, competitive pressures, uncertainties in pharmaceutical pricing, litigation matters (including a DOJ investigation), supply chain disruptions due to external events, and risks related to the generics program and potential goodwill impairment of the At-Home unit.
04—Continue